Analystreport

Aimmune Therapeutics Inc (NASDAQ: AIMT) was downgraded by analysts at Wedbush from an "outperform" rating to a "neutral" rating.

AIMMUNE THERAPEUTICS  (AIMT) 
Last aimmune therapeutics earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.aimmune.com/corporate-profile